Revision history of "Mcintyrebrix7700"

Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • curprev 19:09, 4 September 2024Mcintyrebrix7700 talk contribs 11,928 bytes +11,928 Created page with "progression free survival remains the most common endpoint in phase III trials.<br /><br /> The association of primary oncologist specialty, medical oncology versus gynecologi..."